Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | CDK4 | P11802 | 3/20 | 0.47 |
| ▸ | CDK6 | Q00534 | 3/20 | 0.47 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 4/20 | 0.38 |
| ▸ | MAOB | P27338 | 4/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | REN | P00797 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | METAP2 | P50579 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26329794 | 0.94 | KDM4E (0.51) | KDM4EATML3MBTL1CDK4CDK6 | |
| SCHEMBL26329815 | 0.91 | KDM4E (0.51) | KDM4EATML3MBTL1CDK4CDK6 | |
| SCHEMBL15428469 | 0.91 | KDM4E (0.67) | KDM4EATML3MBTL1CDK4CDK6 | |
| SCHEMBL21454352 | 0.90 | L3MBTL1 (0.47) | KDM4EATML3MBTL1CDK4CDK6 | |
| SCHEMBL26329790 | 0.90 | L3MBTL1 (0.47) | KDM4EATML3MBTL1CDK4CDK6 | |
| SCHEMBL18381787 | 0.90 | KDM4E (0.53) | KDM4EATML3MBTL1CDK4CDK6 | |
| SCHEMBL18357432 | 0.89 | CDK4 (0.49) | KDM4EATML3MBTL1CDK4CDK6 | |
| SCHEMBL16769858 | 0.88 | KDM4E (0.48) | KDM4EATML3MBTL1CDK4CDK6 | |
| SCHEMBL26329843 | 0.88 | KDM4E (0.47) | KDM4EATML3MBTL1CDK4CDK6 | |
| SCHEMBL17279644 | 0.87 | KDM4E (0.62) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11723269-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-08 | — | — | US | disclosed |
| US-11723269-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11723269-B2 | Organic electroluminescent materials and devices | PUF60, CD99, DDT | KDM4E 3163/4885ATM 3362/4885L3MBTL1 1292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.